{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:32:40Z","timestamp":1784543560001,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"H\u00f4pitaux de Paris"},{"name":"BOOSTER innovation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejpb.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T11:39:18Z","timestamp":1442403558000},"page":"396-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations"],"prefix":"10.1016","volume":"96","author":[{"given":"E.","family":"Jubeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yagoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"B\u00e9douet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Slimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Labarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Saint-Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejpb.2015.09.006_b0005","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00005072-199611000-00003","article-title":"Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations","volume":"55","author":"Hatva","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejpb.2015.09.006_b0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2407-12-16","article-title":"Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study","volume":"12","author":"Britten","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejpb.2015.09.006_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","article-title":"Angiogenesis","volume":"57","author":"Folkman","year":"2006","journal-title":"Annu. Rev. Med."},{"issue":"26","key":"10.1016\/j.ejpb.2015.09.006_b0020","first-page":"3075","article-title":"Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives","volume":"17","author":"Welker","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.rli.0000209663.00629.8a","article-title":"Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model","volume":"41","author":"Gupta","year":"2006","journal-title":"Invest. Radiol."},{"issue":"36","key":"10.1016\/j.ejpb.2015.09.006_b0030","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.3748\/wjg.15.4582","article-title":"Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells","volume":"15","author":"Xiao","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13277-011-0164-7","article-title":"Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours","volume":"32","author":"Korse","year":"2011","journal-title":"Tumour Biol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2015.09.006_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006493130855","article-title":"Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling","volume":"50","author":"Patan","year":"2000","journal-title":"J. Neurooncol."},{"issue":"12","key":"10.1016\/j.ejpb.2015.09.006_b0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0165-6147(02)02109-0","article-title":"Recent advances in angiogenesis, anti-angiogenesis and vascular targeting","volume":"23","author":"Bikfalvi","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3816\/CCC.2004.n.006","article-title":"Bevacizumab targeted therapy: validation of angiogenesis as a key target for advanced colorectal cancer","volume":"4","author":"Chu","year":"2004","journal-title":"Clin. Colorectal Cancer"},{"issue":"12","key":"10.1016\/j.ejpb.2015.09.006_b0055","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/nrd1601","article-title":"Bevacizumab","volume":"3","author":"Muhsin","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"26","key":"10.1016\/j.ejpb.2015.09.006_b0060","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3748\/wjg.14.4156","article-title":"VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab","volume":"14","author":"Moehler","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12020-007-0008-9","article-title":"Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines","volume":"31","author":"Hoffmann","year":"2007","journal-title":"Endocrine"},{"issue":"19","key":"10.1016\/j.ejpb.2015.09.006_b0070","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ejpb.2015.09.006_b0075","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"9544","key":"10.1016\/j.ejpb.2015.09.006_b0080","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2015.09.006_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/835680","article-title":"Molecular mechanisms of resistance to tumour anti-angiogenic strategies","volume":"2010","author":"Grepin","year":"2010","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ejpb.2015.09.006_b0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drup.2009.03.002","article-title":"Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies","volume":"12","author":"Rapisarda","year":"2009","journal-title":"Drug Resist. Updates"},{"issue":"3","key":"10.1016\/j.ejpb.2015.09.006_b0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"Paez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.ejpb.2015.09.006_b0110","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1073\/pnas.0902280106","article-title":"G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models","volume":"106","author":"Shojaei","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.ejpb.2015.09.006_b0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1096\/fj.00-0693fje","article-title":"Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival","volume":"15","author":"Reinmuth","year":"2001","journal-title":"FASEB J."},{"issue":"18 Pt 1","key":"10.1016\/j.ejpb.2015.09.006_b0120","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1158\/1078-0432.CCR-04-0823","article-title":"Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option","volume":"10","author":"Leenders","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00330-011-2368-z","article-title":"Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study","volume":"22","author":"Sieghart","year":"2012","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jvir.2009.10.026","article-title":"Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model","volume":"21","author":"Namur","year":"2010","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0135","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jhep.2011.03.024","article-title":"Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants","volume":"55","author":"Namur","year":"2011","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0140","first-page":"S55","article-title":"Abstract No. 140: phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at two institutions","volume":"21","author":"Reyes","year":"2010","journal-title":"J. Vasc. Interv. Radiol.: JVIR"},{"key":"10.1016\/j.ejpb.2015.09.006_b0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2407-12-16","article-title":"Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study","volume":"12","author":"Britten","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejpb.2015.09.006_b0150","first-page":"777","article-title":"N-Butyl-2-cyanoacrylate: substitute for IBCA in interventional neuroradiology-histopathologic and polymerization time studies","volume":"10","author":"Brothers","year":"1989","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0155","first-page":"112","article-title":"Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate","volume":"40","author":"Debrun","year":"1997","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1051-0443(92)72203-9","article-title":"Experimental renal embolization: preliminary results with polyacrylonitrile-based multiblock copolymers","volume":"3","author":"Gu","year":"1992","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0165","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1227\/00006123-199404000-00019","article-title":"Cellulose acetate polymer thrombosis for the emergency treatment of aneurysms: angiographic findings, clinical experience, and histopathological study","volume":"34","author":"Kinugasa","year":"1994","journal-title":"Neurosurgery"},{"issue":"Suppl. A(0)","key":"10.1016\/j.ejpb.2015.09.006_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/jocn.2000.0700","article-title":"Curative treatment of cerebral arteriovenous malformations by embolisation using cellulose acetate polymer followed by surgical resection","volume":"7","author":"Tokunaga","year":"2000","journal-title":"J. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.ejpb.2015.09.006_b0175","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/00006123-200105000-00003","article-title":"Embolization of arteriovenous malformations with onyx: clinicopathological experience in 23 patients","volume":"48","author":"Jahan","year":"2001","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0180","first-page":"304","article-title":"Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system)","volume":"93","author":"Molyneux","year":"2000","journal-title":"J. Neurosurg."},{"issue":"9","key":"10.1016\/j.ejpb.2015.09.006_b0185","first-page":"1726","article-title":"Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices","volume":"21","author":"Murayama","year":"2000","journal-title":"Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.ejpb.2015.09.006_b0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1051-0443(07)61489-4","article-title":"Treatment of type II endoleaks with Onyx","volume":"12","author":"Martin","year":"2001","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejpb.2015.09.006_b0195","first-page":"163","article-title":"A new liquid material for embolization of arteriovenous malformations","volume":"11","author":"Taki W","year":"1990","journal-title":"Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.ejpb.2015.09.006_b0200","first-page":"401","article-title":"A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model","volume":"20","author":"Chaloupka","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0205","first-page":"456","article-title":"Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data","volume":"54","author":"Mottu","year":"2000","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0210","first-page":"64","article-title":"Cardiovascular effects of selected water-miscible solvents for pharmaceutical injections and embolic liquids: a comparative hemodynamic study using a sheep model","volume":"61","author":"Laurent","year":"2007","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0215","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.jvir.2013.01.215","article-title":"Evaluation of the anti-tumoral effect of 70\u2013150\u03bcm sunitinib eluting beads in VX2 carrying rabbits","volume":"24","author":"Bize","year":"2013","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.ejpb.2015.09.006_b0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jvir.2013.11.039","article-title":"Drug-eluting beads loaded with antiangiogenic agents for chemoembolization. In vitro sunitinib loading and release and in vivo pharmacokinetics in an animal model","volume":"25","author":"Fuchs","year":"2014","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"20","key":"10.1016\/j.ejpb.2015.09.006_b0225","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1016\/j.biomaterials.2009.03.021","article-title":"An embolic gelling solution based on acrylic copolymers in ethanol for the treatment of arteriovenous malformations","volume":"30","author":"Seron","year":"2009","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.ejpb.2015.09.006_b0230","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0142-9612(95)00322-3","article-title":"Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators","volume":"17","author":"Vittaz","year":"1996","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.ejpb.2015.09.006_b0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0192623308326151","article-title":"Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors","volume":"36","author":"Patyna","year":"2008","journal-title":"Toxicol. Pathol."},{"issue":"9","key":"10.1016\/j.ejpb.2015.09.006_b0240","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2165\/00002018-200932090-00003","article-title":"Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer","volume":"32","author":"Theou-Anton","year":"2009","journal-title":"Drug Saf."},{"issue":"7","key":"10.1016\/j.ejpb.2015.09.006_b0245","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","article-title":"Sunitinib: from rational design to clinical efficacy","volume":"25","author":"Chow","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0250","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1535-7163.MCT-10-0729","article-title":"Targeted nanogels: a versatile platform for drug delivery to tumors","volume":"10","author":"Murphy","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejpb.2015.09.006_b0255","first-page":"417","article-title":"Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells","volume":"7","author":"Dolman","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mabi.201100277","article-title":"Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue","volume":"12","author":"Dolman","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2015.09.006_b0265","unstructured":"J.P. Devissaguet, H. Fessi, F. Puisieux, C. Thies, Proc\u00e9d\u00e9 de pr\u00e9paration de syst\u00e8mes collo\u00efdaux dispersibles d\u2019une substance sous forme de nanoparticules, France Patent N 8618446 1986, 1986."},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0270","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/1078-0432.CCR-07-1562","article-title":"Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy","volume":"14","author":"Blansfield","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ejpb.2015.09.006_b0275","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1442-9071.2009.02112.x","article-title":"Effect of bevacizumab on corneal neovascularization in experimental rabbit model","volume":"37","author":"Ahmed","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejpb.2015.09.006_b0280","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ejpb.2015.09.006_b0285","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1021\/bm800664c","article-title":"Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha","volume":"9","author":"Bouclier","year":"2008","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc700227z","article-title":"PLGA nanoparticle\u2013peptide conjugate effectively targets intercellular cell-adhesion molecule-1","volume":"19","author":"Zhang","year":"2008","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2214\/ajr.160.1.8416618","article-title":"Fluid flow during percutaneous drainage procedures: an in vitro study of the effects of fluid viscosity, catheter size, and adjunctive urokinase","volume":"160","author":"Park","year":"1993","journal-title":"AJR Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0300","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICO.0b013e3181b1c82f","article-title":"The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits","volume":"29","author":"Kang","year":"2010","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0305","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00417-008-0976-3","article-title":"Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization","volume":"247","author":"Han","year":"2009","journal-title":"Graef Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.ejpb.2015.09.006_b0310","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","article-title":"Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis","volume":"247","author":"Saravia","year":"2009","journal-title":"Graef Arch. Clin. Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"Perez-Santonja","year":"2010","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jbm.b.30286","article-title":"Thermogelling emulsions for vascular embolization and sustained release of drugs","volume":"75B","author":"Kan","year":"2005","journal-title":"J. Biomed. Mater. Res. B: Appl. Biomater."},{"key":"10.1016\/j.ejpb.2015.09.006_b0325","first-page":"1","article-title":"VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2","author":"Han","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejpb.2015.09.006_b0330","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/SCS.0b013e3181927f1e","article-title":"Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child","volume":"20","author":"Burrows","year":"2009","journal-title":"J. Craniofac. Surg."},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2015.09.006_b0335","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000343835","article-title":"Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma","volume":"1","author":"Liapi","year":"2012","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.ejpb.2015.09.006_b0340","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00330-004-2517-8","article-title":"Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model","volume":"15","author":"Maataoui","year":"2005","journal-title":"Eur. Radiol."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0345","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00270-011-0179-x","article-title":"Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor","volume":"34","author":"Deng","year":"2011","journal-title":"Cardiovasc. Interv. Radiol."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0350","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ijc.22655","article-title":"Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas","volume":"121","author":"Jiang","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0355","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3748\/wjg.v10.i6.813","article-title":"Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2015.09.006_b0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00112-0","article-title":"Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2015.09.006_b0365","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100102197","article-title":"Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method","volume":"25","author":"Barichello","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2015.09.006_b0370","first-page":"173","article-title":"Drug loaded nanoparticles preparation methods and drug targeting issues","volume":"39","author":"All\u00e9mann","year":"1993","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0375","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/bm501519u","article-title":"Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles","volume":"16","author":"Yang","year":"2015","journal-title":"Biomacromolecules"},{"issue":"11","key":"10.1016\/j.ejpb.2015.09.006_b0380","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11748-013-0269-6","article-title":"Repeated embolization of intercostal arteries after blunt chest injury","volume":"62","author":"Nemoto","year":"2014","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0385","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/jocs.12012","article-title":"Posterior intercostal hemorrhage following median sternotomy","volume":"27","author":"Soquet","year":"2012","journal-title":"J. Card. Surg."},{"issue":"6","key":"10.1016\/j.ejpb.2015.09.006_b0390","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3348\/kjr.2011.12.6.693","article-title":"Hepatocellular carcinomas smaller than 4cm supplied by the intercostal artery: can we predict which intercostal artery supplies the tumor","volume":"12","author":"Hur S","year":"2011","journal-title":"Korean J. Radiol."},{"issue":"3","key":"10.1016\/j.ejpb.2015.09.006_b0395","first-page":"357","article-title":"A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization","volume":"15","author":"Jung","year":"2009","journal-title":"Clin. Mol. Hepatol."},{"issue":"5","key":"10.1016\/j.ejpb.2015.09.006_b0400","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejvs.2014.08.004","article-title":"Ethanol embolotherapy of high-flow auricular arteriovenous malformations with electrolytically detachable coil-assisted dominant outflow vein occlusion","volume":"48","author":"Wang","year":"2014","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"2","key":"10.1016\/j.ejpb.2015.09.006_b0405","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1148\/radiol.2352040449","article-title":"Ethanol embolization of arteriovenous malformations: interim results","volume":"235","author":"Young Soo","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.ejpb.2015.09.006_b0410","unstructured":"M.T. Baylatry, D. Labarre, A. Laurent, L. Moine, J-P. Saint-Maurice, K. Slimani, M. Wassef, Injectable Biomaterial. US 8673264 B2\/EP2403483A2, 2010."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115003847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115003847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T16:49:50Z","timestamp":1567183790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641115003847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":82,"alternative-id":["S0939641115003847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.09.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}